Primary |
Drug Use For Unknown Indication |
46.9% |
Stent Placement |
11.4% |
Hypertension |
5.9% |
Acute Coronary Syndrome |
3.7% |
Myocardial Infarction |
3.7% |
Prophylaxis |
3.7% |
Transient Ischaemic Attack |
3.7% |
Suicide Attempt |
2.9% |
Cerebrovascular Accident |
2.6% |
Agitation |
2.2% |
Antiplatelet Therapy |
2.2% |
Diabetes Mellitus |
1.8% |
Coronary Artery Disease |
1.5% |
Oedema |
1.5% |
Aortic Valve Replacement |
1.1% |
Atrial Fibrillation |
1.1% |
Coronary Angioplasty |
1.1% |
Encephalopathy |
1.1% |
Product Used For Unknown Indication |
1.1% |
Type Ii Diabetes Mellitus |
1.1% |
|
Thrombosis In Device |
11.1% |
Leukopenia |
8.9% |
Pulmonary Fibrosis |
8.9% |
Gastric Ulcer |
6.7% |
Vascular Occlusion |
6.7% |
Atrial Fibrillation |
4.4% |
Cerebrovascular Accident |
4.4% |
Confusional State |
4.4% |
Pancytopenia |
4.4% |
Rhabdomyolysis |
4.4% |
Skin Exfoliation |
4.4% |
Somnolence |
4.4% |
Stevens-johnson Syndrome |
4.4% |
Thrombosis |
4.4% |
Ventricular Extrasystoles |
4.4% |
Weight Decreased |
4.4% |
Amnesia |
2.2% |
Aortic Aneurysm Rupture |
2.2% |
Aplasia Pure Red Cell |
2.2% |
Condition Aggravated |
2.2% |
|
Secondary |
Hypertension |
17.4% |
Drug Use For Unknown Indication |
14.7% |
Diabetes Mellitus |
9.3% |
Coronary Artery Disease |
6.3% |
Cerebral Haemorrhage |
5.7% |
Myocardial Infarction |
5.7% |
Stent Placement |
5.2% |
Sleep Disorder |
3.8% |
Depression |
3.4% |
Muscle Spasticity |
3.4% |
Platelet Aggregation |
3.4% |
Thrombosis Prophylaxis |
3.4% |
Pain |
2.9% |
Hypokalaemia |
2.7% |
Prophylaxis |
2.5% |
Hyperthyroidism |
2.3% |
Polyuria |
2.3% |
Hyperlipidaemia |
2.0% |
Agitation |
1.8% |
Coronary Angioplasty |
1.8% |
|
Gastric Ulcer |
21.4% |
Thrombosis In Device |
10.0% |
Pancytopenia |
7.1% |
Haemorrhoidal Haemorrhage |
5.7% |
Swollen Tongue |
5.7% |
Gastrointestinal Haemorrhage |
4.3% |
Hepatitis |
4.3% |
In-stent Arterial Restenosis |
4.3% |
Oesophagitis Haemorrhagic |
4.3% |
Ventricular Flutter |
4.3% |
Cerebrovascular Accident |
2.9% |
Confusional State |
2.9% |
Gastrointestinal Ulcer Haemorrhage |
2.9% |
Pulmonary Fibrosis |
2.9% |
Retinal Vein Thrombosis |
2.9% |
Rhabdomyolysis |
2.9% |
Syncope |
2.9% |
Thrombosis |
2.9% |
Type 1 Diabetes Mellitus |
2.9% |
Ventricular Arrhythmia |
2.9% |
|
Concomitant |
Drug Use For Unknown Indication |
19.6% |
Hypertension |
19.0% |
Product Used For Unknown Indication |
14.9% |
Coronary Artery Disease |
5.6% |
Prophylaxis Of Nausea And Vomiting |
4.5% |
Rheumatoid Arthritis |
4.3% |
Type 2 Diabetes Mellitus |
3.4% |
Pain |
2.9% |
Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
Urinary Tract Infection |
2.7% |
Hyperparathyroidism Secondary |
2.6% |
Prophylaxis |
2.4% |
Depression |
2.3% |
Diabetes Mellitus |
2.3% |
Hyperlipidaemia |
2.3% |
Osteoporosis |
2.0% |
Atrial Fibrillation |
1.8% |
Ischaemic Heart Disease Prophylaxis |
1.6% |
Myocardial Infarction |
1.5% |
Hyperuricaemia |
1.5% |
|
Myocardial Infarction |
9.6% |
Faecaloma |
7.0% |
Progressive Multifocal Leukoencephalopathy |
7.0% |
Hyponatraemia |
6.1% |
Syncope |
6.1% |
Transplant Failure |
6.1% |
Somnolence |
5.3% |
Staphylococcal Bacteraemia |
5.3% |
Vomiting |
5.3% |
Clostridium Difficile Colitis |
4.4% |
Hypophagia |
4.4% |
Nausea |
4.4% |
Paralysis |
4.4% |
Atrial Fibrillation |
3.5% |
Gastrointestinal Ulcer Haemorrhage |
3.5% |
Hypertension |
3.5% |
Hypertensive Crisis |
3.5% |
Hypokalaemia |
3.5% |
Rash Maculo-papular |
3.5% |
Renal Failure Acute |
3.5% |
|
Interacting |
Coronary Artery Disease |
14.7% |
Hypertension |
13.5% |
Encephalopathy |
8.8% |
Diabetes Mellitus |
8.2% |
Leukoencephalopathy |
8.2% |
Aphasia |
5.9% |
Hashimoto's Encephalopathy |
5.3% |
Reflux Oesophagitis |
4.7% |
Osteoporosis Prophylaxis |
4.1% |
Renal Failure Chronic |
3.5% |
Atrial Fibrillation |
2.9% |
Carotid Artery Stenosis |
2.9% |
Convulsion |
2.9% |
Transient Ischaemic Attack |
2.9% |
Colitis Ulcerative |
2.4% |
Drug Use For Unknown Indication |
2.4% |
Dyslipidaemia |
2.4% |
Angina Pectoris |
1.8% |
Cardiovascular Event Prophylaxis |
1.2% |
Hyperlipidaemia |
1.2% |
|
Pancytopenia |
30.4% |
Drug Interaction |
21.7% |
Pyrexia |
13.0% |
Hepatocellular Injury |
8.7% |
Haemorrhagic Anaemia |
4.3% |
Neoplasm |
4.3% |
Oesophagitis Haemorrhagic |
4.3% |
Paraesthesia |
4.3% |
Paraplegia |
4.3% |
Upper Gastrointestinal Haemorrhage |
4.3% |
|